1. Home
  2. BTG vs TMDX Comparison

BTG vs TMDX Comparison

Compare BTG & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTG
  • TMDX
  • Stock Information
  • Founded
  • BTG 2006
  • TMDX 1998
  • Country
  • BTG Canada
  • TMDX United States
  • Employees
  • BTG N/A
  • TMDX N/A
  • Industry
  • BTG Precious Metals
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BTG Basic Materials
  • TMDX Health Care
  • Exchange
  • BTG Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • BTG 4.2B
  • TMDX 4.7B
  • IPO Year
  • BTG N/A
  • TMDX 2019
  • Fundamental
  • Price
  • BTG $2.68
  • TMDX $80.48
  • Analyst Decision
  • BTG Buy
  • TMDX Buy
  • Analyst Count
  • BTG 3
  • TMDX 10
  • Target Price
  • BTG $4.12
  • TMDX $138.20
  • AVG Volume (30 Days)
  • BTG 14.5M
  • TMDX 2.3M
  • Earning Date
  • BTG 11-06-2024
  • TMDX 10-28-2024
  • Dividend Yield
  • BTG 5.97%
  • TMDX N/A
  • EPS Growth
  • BTG N/A
  • TMDX N/A
  • EPS
  • BTG N/A
  • TMDX 0.94
  • Revenue
  • BTG $1,914,216,000.00
  • TMDX $401,090,000.00
  • Revenue This Year
  • BTG N/A
  • TMDX $83.25
  • Revenue Next Year
  • BTG $34.69
  • TMDX $26.27
  • P/E Ratio
  • BTG N/A
  • TMDX $85.88
  • Revenue Growth
  • BTG N/A
  • TMDX 109.09
  • 52 Week Low
  • BTG $2.34
  • TMDX $66.76
  • 52 Week High
  • BTG $3.50
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • BTG 25.09
  • TMDX 27.29
  • Support Level
  • BTG $2.66
  • TMDX $82.70
  • Resistance Level
  • BTG $3.44
  • TMDX $98.88
  • Average True Range (ATR)
  • BTG 0.12
  • TMDX 5.58
  • MACD
  • BTG -0.08
  • TMDX 1.01
  • Stochastic Oscillator
  • BTG 1.92
  • TMDX 3.06

About BTG B2Gold Corp Common shares (Canada)

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other significant assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into a global market. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: